241 related articles for article (PubMed ID: 21806945)
1. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.
Singh H; Nugent Z; Demers AA; Bernstein CN
Gastroenterology; 2011 Nov; 141(5):1612-20. PubMed ID: 21806945
[TBL] [Abstract][Full Text] [Related]
2. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
Peyrin-Biroulet L; Khosrotehrani K; Carrat F; Bouvier AM; Chevaux JB; Simon T; Carbonnel F; Colombel JF; Dupas JL; Godeberge P; Hugot JP; Lémann M; Nahon S; Sabaté JM; Tucat G; Beaugerie L;
Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105
[TBL] [Abstract][Full Text] [Related]
3. Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
Narous M; Nugent Z; Singh H; Bernstein CN
Inflamm Bowel Dis; 2023 Jul; 29(7):1047-1056. PubMed ID: 35929649
[TBL] [Abstract][Full Text] [Related]
4. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
5. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study.
Singh H; Demers AA; Nugent Z; Mahmud SM; Kliewer EV; Bernstein CN
Gastroenterology; 2009 Feb; 136(2):451-8. PubMed ID: 18996382
[TBL] [Abstract][Full Text] [Related]
6. Thiopurines for inflammatory bowel disease: time to engage with dermatologists?
Jess T
Gastroenterology; 2011 Nov; 141(5):1549-51. PubMed ID: 21945060
[No Abstract] [Full Text] [Related]
7. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.
Scott FI; Mamtani R; Brensinger CM; Haynes K; Chiesa-Fuxench ZC; Zhang J; Chen L; Xie F; Yun H; Osterman MT; Beukelman T; Margolis DJ; Curtis JR; Lewis JD
JAMA Dermatol; 2016 Feb; 152(2):164-72. PubMed ID: 26510126
[TBL] [Abstract][Full Text] [Related]
8. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
Ariyaratnam J; Subramanian V
Am J Gastroenterol; 2014 Feb; 109(2):163-9. PubMed ID: 24419479
[TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
[TBL] [Abstract][Full Text] [Related]
10. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.
Long MD; Herfarth HH; Pipkin CA; Porter CQ; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2010 Mar; 8(3):268-74. PubMed ID: 20005977
[TBL] [Abstract][Full Text] [Related]
11. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
13. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression.
Wang LE; Li C; Strom SS; Goldberg LH; Brewster A; Guo Z; Qiao Y; Clayman GL; Lee JJ; El-Naggar AK; Prieto VG; Duvic M; Lippman SM; Weber RS; Kripke ML; Wei Q
Clin Cancer Res; 2007 Nov; 13(21):6532-9. PubMed ID: 17975167
[TBL] [Abstract][Full Text] [Related]
14. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B
Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529
[TBL] [Abstract][Full Text] [Related]
15. Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer.
Paradisi A; Waterboer T; Sampogna F; Tabolli S; Simoni S; Pawlita M; Abeni D
Br J Dermatol; 2011 Oct; 165(4):782-91. PubMed ID: 21561438
[TBL] [Abstract][Full Text] [Related]
16. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
[TBL] [Abstract][Full Text] [Related]
17. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
Rungoe C; Basit S; Ranthe MF; Wohlfahrt J; Langholz E; Jess T
Gut; 2013 May; 62(5):689-94. PubMed ID: 22961677
[TBL] [Abstract][Full Text] [Related]
18. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
[TBL] [Abstract][Full Text] [Related]
19. Screening differences and risk of cervical cancer in inflammatory bowel disease.
Hutfless S; Fireman B; Kane S; Herrinton LJ
Aliment Pharmacol Ther; 2008 Sep; 28(5):598-605. PubMed ID: 18549465
[TBL] [Abstract][Full Text] [Related]
20. Repeated Occurrences of Basal Cell Cancer in Patients With Inflammatory Bowel Disease Treated With Immunosuppressive Medications.
Khan N; Patel D; Trivedi C; Kavani H; Medvedeva E; Pernes T; Xie D; Lewis J; Yang YX
Am J Gastroenterol; 2020 Aug; 115(8):1246-1252. PubMed ID: 32453047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
